Bioscience Neutraceuticals, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced operating loss was USD 459,750 compared to USD 36,300 a year ago. Net loss was USD 626,046 compared to USD 73,538 a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.3 a year ago.